PREVENTION OF ERYSIPELAS IN THE EARLY POSTOPERATIVE PERIOD AFTER THE IMPOSITION MIKROLIMFOVEIN ANASTOMOSIS IN PATIENTS AFTER BREAST CANCER LYMPHEDEMA

Abstract

The aim of work is valuation of the effectiveness of autologous lymphocytes activated by complex of cytokines to prevent erysipelas of patients with after breast cancer syndrome.The estimate of influence of activated autologous lymphocytes to erysipelas. The treatment results of 128 patients with secondary lymphedema of the upper limb II–III stage after curative treatment of breast cancer are included in the work.Activated roncoleukin auto lymphocytes injections were performed in the forearm of the affected limb to the main group’s patients.17.4% faces relapses were recorded in the comparison group. while the group with the usage of activated roncoleukin autologous lymphocytes had achieved significant reductions in recurrent of erysipelas up to 5%.

Keywords

• профилактика рожи, лимфедема, постмастэктомический синдром, аутоло-гичные лимфоциты, активированные интерлейкином-2